318160 — Cell Bio Human Tech Co Balance Sheet

0.000.00%

Last trade - 00:00

Consumer CyclicalsHighly SpeculativeMicro CapContrarian

Annual balance sheet for Cell Bio Human Tech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	29,901	12,643	21,385	6,895	13,485
Net Total Accounts Receivable
Net Total Receivables	4,327	5,624	3,766	3,104	4,337
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	37,137	23,406	32,071	19,936	26,918
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8,490	20,983	23,904	23,152	22,764
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	49,780	47,896	58,069	45,982	53,196
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,123	3,185	19,477	13,706	8,559
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	2,331	3,805	29,202	13,835	8,634
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Other Equity
Total Equity	47,449	44,091	28,867	32,147	44,563
Total Liabilities & Shareholders' Equity	49,780	47,896	58,069	45,982	53,196
Total Common Shares Outstanding
Total Preferred Shares Outstanding